Ventas Stock Price, News & Analysis

Ventas, Inc. (NYSE: VTR) announced its participation in investor meetings at Nareit’s REITworld 2022 Annual Conference on November 15-16, 2022. Accompanying materials will be available on the Company’s website around November 14, 2022, and archived for a limited time thereafter.

Ventas is an S&P 500 company operating in healthcare and real estate, with over 1,200 properties across the U.S., Canada, and the UK. The Company focuses on senior living, life sciences, and healthcare real estate, backed by a 20-year successful diversification strategy.

Ventas (NYSE: VTR) reported its Q3 2022 financial results, revealing a net income attributable to common stockholders of $0.00 per share, while Normalized FFO was $0.76, benefiting from $20 million in HHS grants. The company's same-store cash Net Operating Income (NOI) grew 4.8%, with the Senior Housing Operating Portfolio (SHOP) segment seeing a significant 13% increase. Ventas anticipates Q4 growth in SHOP cash NOI ranging from 15% to 21%, despite challenges from rising interest rates. The company maintains a strong balance sheet with $2.5 billion in liquidity and favorable debt maturity profiles.

Ventas, Inc. (NYSE: VTR) will release its third quarter 2022 earnings on November 3, 2022, after the market closes. A conference call to discuss these results is scheduled for November 4, 2022, at 10:00 a.m. ET. Investors can participate via a dial-in number or through a live webcast available on www.ventasreit.com. Ventas operates over 1,200 properties across the U.S., Canada, and the U.K., focusing on healthcare and real estate sectors driven by the growing aging population.

Ardent Health Services has appointed Carlene Callis as chief system integration and growth officer and Ben Jacobs as chief strategy and development officer. Callis will enhance care delivery and operational efficiency across the organization. With over 25 years in healthcare, she previously served at HCA. Jacobs, with nearly two decades of experience, will focus on strategic planning and expansion into new markets. Both leaders aim to strengthen Ardent’s mission of improving community healthcare access.

Ventas, Inc. (NYSE: VTR) announced its participation in investor meetings at the Mizuho Healthcare REIT Conference on October 4, 2022. Written materials for the event will be available on the Company's website around the same date, and these will be archived for a limited time.

Ventas operates over 1,200 properties across the United States, Canada, and the United Kingdom, focusing on healthcare and real estate. The company’s strategy emphasizes diversification and financial strength, aimed at unlocking value in senior living and healthcare real estate.

Ventas, Inc. (NYSE: VTR) has declared a quarterly dividend of $0.45 per share, payable on October 14, 2022, to stockholders recorded by the close of business on October 3, 2022.

As a leading real estate investment trust, Ventas operates in healthcare and real estate sectors with a portfolio of over 1,200 properties across the United States, Canada, and the United Kingdom. The company leverages its capital to enhance senior living, life science, and healthcare real estate.

Ventas, Inc. (NYSE: VTR) announced that CEO Debra A. Cafaro will receive the Women Corporate Directors (WCD) 2022 Visionary Award for Strategic Leadership. This award honors women leaders who promote diversity and long-term growth. Under Cafaro's leadership since 1999, Ventas's market capitalization surged from $200 million to $25 billion by 2022. The company is recognized for its commitment to environmental, social, and governance standards and for fostering a diverse workforce.